language English
Article 2026 · 0 atıf

NiCo<sub>2</sub>O<sub>4</sub> nanoparticles as chemosensitizers: enhancing doxorubicin-induced intrinsic apoptosis in A549 and MCF-7 cells

Palabiyik, Esra, Avci, Bahri, Sulumer, Ayse Nurseli, Askin, Hakan, Uguz, Handan

Özet

Bimetallic spinel NiCo2O4 nanoparticles (NPs) were synthesized via hydrothermal methods and characterized by XRD, SEM, and EDX analyses. This study investigated their cytotoxic, synergistic, and pro-apoptotic effects-alone and in combination with doxorubicin (Dox)-in lung (A549) and breast (MCF-7) cancer cells, with the BEAS-2B normal epithelial line serving as a non-malignant control. Cytotoxicity was evaluated by WST-8 assays, and IC50 values were determined through four-parameter logistic (4PL) non-linear regression. The Combination Index (CI) was computed using the Chou-Talalay method to confirm the synergistic interaction. qRT-PCR quantified CASP6, BAX, and BCL2 expression to elucidate intrinsic apoptotic activation. NiCo2O4 alone displayed moderate cytotoxicity (IC50 approximate to 176 mu g/mL), while Dox showed higher potency (0.089-1.48 mu M). Combination treatment reduced IC50 to 12.86 mu g/mL in MCF-7 and 7.87 mu g/mL in A549 cells, with mean CI < 1 confirming genuine synergy. CASP6 and BAX were strongly upregulated (3-fivefold) and BCL2 was suppressed (similar to 0.3-fold), indicating enhanced intrinsic apoptosis. Notably, NiCo2O4 demonstrated preferential toxicity toward cancer cells compared with BEAS-2B controls (selectivity index approximate to 1.96). These results establish NiCo2O4 as a dual-function nanomaterial-both cytotoxic and chemosensitizing-capable of amplifying doxorubicin efficacy via mitochondrial and caspase-dependent pathways. Its synergistic activity and favorable selectivity highlight the translational potential of NiCo2O4-based nanochemosensitization strategies.

Anahtar Kelimeler
NiCo2O4 nanoparticles Doxorubicin Apoptosis Synergy Cancer selectivity SPINEL NICO2O4 CANCER
WoS Kategorileri
Pharmacology & Pharmacy
Sürdürülebilir Kalkınma Amaçları
Künye
Dergi
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Yıl
2026
Cilt
399
Sayı
4
Sayfa
5793-5808
ISSN
0028-1298
eISSN
1432-1912
DOI
10.1007/s00210-025-04789-2
WoS UID
WOS:001615441700001
Yayını aç (DOI)